Search Results 91-100 of 18082 for multiple%20sclerosis

  1. Membership - Center for Multiple Sclerosis and Autoimmune Neurology - Mayo Clinic Research

    Faculty members conducting research through the Center for Multiple Sclerosis and Autoimmune Neurology at Mayo Clinic have wide-ranging expertise.

  2. Membership - Center for Multiple Sclerosis and Autoimmune Neurology - Mayo Clinic Research

    Faculty members conducting research through the Center for Multiple Sclerosis and Autoimmune Neurology at Mayo Clinic have wide-ranging expertise.

  3. Membership - Center for Multiple Sclerosis and Autoimmune Neurology - Mayo Clinic Research

    Faculty members conducting research through the Center for Multiple Sclerosis and Autoimmune Neurology at Mayo Clinic have wide-ranging expertise.

  4. Transverse myelitis - Symptoms & causes - Mayo Clinic

    Causes · Multiple sclerosis is a disorder in which the immune system destroys myelin surrounding nerves in your spinal cord and brain. · Neuromyelitis optica ( ...

  5. A Study to Determine the Effectiveness of Early Intensive vs. Escalation Approach to Treat Relapsing/Remitting Multiple Sclerosis - Mayo Clinic

    Escalation Approach to Treat Relapsing/Remitting Multiple Sclerosis. Print ... Rochester, Minnesota: 20-010227. NCT ID: NCT03535298. Sponsor Protocol ...

  6. Collaborative programs - Center for Multiple Sclerosis and Autoimmune Neurology - Mayo Clinic Research

    The Center for Multiple Sclerosis and Autoimmune Neurology at Mayo Clinic collaborates with numerous labs and investigators on neurological research.

  7. A Study of the Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) - Mayo Clinic

    ... 20% in the last two years sustained for at least 6 months or c) other well-documented objective worsening validated by the Adjudication Committee; EDSS at ...

  8. Study Shows Halting an Enzyme Can Slow Multiple Sclerosis in Mice - Mayo Clinic News Network

    ROCHESTER, Minn. — Researchers studying multiple sclerosis (MS) have long been looking for the specific molecules in the body that cause lesions in myelin, ...

  9. An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab - Mayo Clinic

    This open-label, rater-blinded extension study will enroll patients who have relapsing-remitting multiple sclerosis (RRMS) and who participated in one of three ...

  10. New antibody test for MS diagnosis - Mayo Clinic

    Mayo Clinic researchers have validated a new antibody test for the diagnosis of multiple sclerosis (MS). ... 20 minutes. The researchers analyzed paired ...